SK Capital Partners to buy affordable pharma business Apotex
The investment by SK Capital will support Apotex’s next phase of growth and continued innovation for patient affordability.
The investment by SK Capital will support Apotex’s next phase of growth and continued innovation for patient affordability.
Copyright PEI Media
Not for publication, email or dissemination